Comparing TSH suppression methods for advanced thyroid cancer
Treatments studied
Part of Cancer, Hormones & metabolism clinical trials.
This study compares two methods to lower a hormone called TSH that can make thyroid cancer grow. It is for people with advanced thyroid cancer who live in Alberta and can come to Edmonton for treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced differentiated thyroid cancer (including papillary, follicular, or other types) that cannot be fully removed by surgery or has spread to other parts of the body.
- You live in Alberta and are willing to be treated at the Cross Cancer Institute in Edmonton.
- You are able to walk and take care of yourself (ECOG score 0-2).
- You have thyroid cancer tissue available for testing (from a previous surgery or biopsy).
- You do not have a recent heart attack, atrial fibrillation, or osteoporosis with fractures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for patients with a small thyroid cancer (1 cm or less) that is not aggressive. It tests whether taking thyroid hormone to keep TSH low is necessary during active surveillance (watching the cancer closely instead of removing it right away).
This trial tests whether a combination of two thyroid hormone medications can better suppress TSH in people with differentiated thyroid cancer. It may help those who have not reached their TSH target with standard levothyroxine alone.
This trial tests whether a medicine called recombinant human thyroid stimulating hormone (rhTSH) can help prepare your body for radioactive iodine (131I) treatment, which aims to destroy any remaining or spreading thyroid cancer cells. It may be a good option if your thyroid cancer has come back or spread and you are able to have radioactive iodine therapy.
This study tests if a man-made hormone (rhTSH) can make radioactive iodine therapy more effective for people with advanced thyroid cancer that has come back or spread. It aims to see if it helps find and treat cancer that doesn't respond well to standard radioactive iodine.
This trial tests if an existing drug (used for other conditions) can help people with advanced thyroid cancer who have run out of treatment options. You'll get a new drug and be monitored to see if it shrinks your cancer or slows it down.
This study tests a new approach for people with hypothyroidism who are already taking levothyroxine. You may be able to join if you are on a certain dose and do not have other health conditions that could affect the results.
Hear when a new Advanced Differentiated Thyroid Gland Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.